Data modeling methods in clinical trials: experiences from the clinical trial methods in neurodegenerative diseases project

被引:0
|
作者
Athanasios Anastasiou
Emmanuel Ifeachor
John Zajicek
机构
[1] University of Plymouth,Signal Processing and Multimedia Communications Research Group
[2] Institute of Health Service Research (Peninsula College of Medicine and Dentistry,undefined
关键词
Neurodegenerative Disease; Support Clinical Decision; Object Management Group; Software Maintenance; High Level Model;
D O I
10.1186/1745-6215-12-S1-A15
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Drugs and clinical trials in neurodegenerative diseases
    Stanzione, Paolo
    Tropepi, Domenicantonio
    ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2011, 47 (01): : 49 - 54
  • [2] Neural Cells for Neurodegenerative Diseases in Clinical Trials
    Fan, Yiping
    Goh, Eyleen L. K.
    Chan, Jerry Kok Yen
    STEM CELLS TRANSLATIONAL MEDICINE, 2023, 12 (08) : 510 - 526
  • [3] Improved modeling of clinical data with kernel methods
    Daemen, Anneleen
    Timmerman, Dirk
    Van den Bosch, Thierry
    Bottomley, Cecilia
    Kirk, Emma
    Van Holsbeke, Caroline
    Valentin, Lil
    Bourne, Tom
    De Moor, Bart
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2012, 54 (02) : 103 - 114
  • [4] Missing Data in Alcohol Clinical Trials: A Comparison of Methods
    Hallgren, Kevin A.
    Witkiewitz, Katie
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 37 (12) : 2152 - 2160
  • [5] Applying sample survey methods to clinical trials data
    LaVange, LM
    Koch, GG
    Schwartz, TA
    STATISTICS IN MEDICINE, 2001, 20 (17-18) : 2609 - 2623
  • [6] Comparison of binary data imputation methods in clinical trials
    An, Koosung
    Kim, Dongjae
    KOREAN JOURNAL OF APPLIED STATISTICS, 2016, 29 (03) : 539 - 547
  • [7] MISSING DATA IN ALCOHOL CLINICAL TRIALS: A COMPARISON OF METHODS
    Hallgren, K. A.
    Witkiewitz, K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 : 137A - 137A
  • [8] Methods for Missing Data Handling in Randomized Clinical Trials With Nonnormal Endpoints With Application to a Phase III Clinical Trial
    Fan, Chunpeng
    Zhang, Donghui
    Wei, Lynn
    Koch, Gary
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2016, 8 (02): : 179 - 193
  • [9] The role of placebo control in clinical trials for neurodegenerative diseases
    Mehta, Arpan R.
    Carpenter, James R.
    Nicholas, Jennifer M.
    Chataway, Jeremy
    Virgo, Bruce
    Parmar, Mahesh K. B.
    Chandran, Siddharthan
    Pal, Suvankar
    NATURE MEDICINE, 2023, 29 (11) : 2682 - 2683
  • [10] Methods for improving clinical trials
    Cleophas, TJ
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1999, 37 (11-12) : 1035 - 1041